Skip to main navigation Skip to search Skip to main content

Hesperetin’s health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations

  • Bahare Salehi
  • , Natália Cruz-Martins
  • , Monica Butnariu
  • , Ioan Sarac
  • , Iulia Cristina Bagiu
  • , Shahira M. Ezzat
  • , Jinfan Wang
  • , Aaron Koay
  • , Helen Sheridan
  • , Charles Oluwaseun Adetunji
  • , Prabhakar Semwal
  • , Mauricio Schoebitz
  • , Miquel Martorell
  • , Javad Sharifi-Rad
  • Shahid Beheshti University of Medical Sciences
  • University of Porto
  • Banat University of Agricultural Sciences and Veterinary Medicine
  • Victor Babes University of Medicine and Pharmacy
  • Cairo University
  • October University for Modern Sciences and Arts
  • Trinity College Dublin
  • Edo University Iyamho
  • Graphic Era
  • Uttarakhand State Council for Science and Technology
  • Universidad de Concepción
  • Universidad del Azuay

Research output: Contribution to journalReview articlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Hesperetin’s health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science